Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersGeneral Practice Physician in Minneapolis, MN
NPI: 1427034438HQ Phone
Get Michael's Phone Numberphone_androidMobile
Get Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMN State Medical License
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor.
Authors: Marc Riedl, Donald Levy, Iftikhar Hussain, Robert Nathan, Richard Gower, Timothy Craig, Jonathan Edelman, Bruce Zuraw, Aleena Banerji, Huamin Li
Publication Date: 2017-03-23
Berotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: Review of phase II and III studies.
Authors: Jay Kashkin
Publication Date: 2021-06-15
Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema.
Authors: Richard Gower, Martha White
Publication Date: 2013-06-27
Lead Sponsor: COUR Pharmaceutical Development Company, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: CNP-201
Lead Sponsor: Shire
Collaborators: Takeda Development Center Americas, Inc.
Intervention / Treatment: DRUG: Lanadelumab
Lead Sponsor: Shire
Collaborators: Takeda Development Center Americas, Inc.